Business NewsPR NewsWire • Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019

Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019

Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019

THOUSAND OAKS, Calif., Sept. 27, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutant solid tumors. The data include the first evidence of anti-tumor activity reported in...

View More : https://www.prnewswire.com:443/news-releases/amgen-announces-new-clinical-data-evaluating-novel-investigational-krasg12c...
Releted News by prnewswire
Suning Completes Acquisition of Carrefour China, Accelerating Full-Scenario Retail Layout
Am 29. September 2019 ist Weltherztag: World Heart Federation (WHF) ruft zu Chancengleichheit im Bereich der Herzgesundheit auf, denn jedes Herz, das schlägt, zählt
À l'occasion de la Journée mondiale du cœur, le 29 septembre 2019, la Fédération mondiale du cœur (FMC) appelle à l'égalité en matière de santé cardiaque car chaque battement de cœur compte
Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019
FORMER LOUSIANA ATTORNEY GENERAL'S LAW FIRM Kahn Swick & Foti, LLC Files a Securities Class Action Against Waitr Holdings Inc. f/k/a Landcadia Holdings, Inc. ‑‑ (NasdaqGS: WTRH)
FORMER LOUSIANA ATTORNEY GENERAL'S LAW FIRM Kahn Swick & Foti, LLC Files a Securities Class Action Against Overstock.com, Inc. ‑‑ (NasdaqGS: OSTK)
Shell Enhances Quarterly Disclosures